Meprobamate and Haldol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meprobamate (meprobamate) and Haldol (haloperidol). Common drug interactions include hepatic cirrhosis among females and blood urea increased among males.

The phase IV clinical study analyzes what interactions people have when they take Meprobamate and Haldol. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Meprobamate?

Meprobamate has active ingredients of meprobamate. It is often used in stress and anxiety. eHealthMe is studying from 2,268 Meprobamate users. Check the latest studies of Meprobamate.

What is Haldol?

Haldol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 23,102 Haldol users. Check the latest studies of Haldol.

On Jul, 12, 2026

11 people who take Meprobamate and Haldol together, and have interactions are studied.

Meprobamate and Haldol drug interactions.

What are the common drug interactions of Meprobamate and Haldol, by gender? *:

female:

Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic neoplasm (liver tumour)
Pain
Constipation
Diarrhoea
Dyspepsia (indigestion)
Hepatic necrosis (large portions of liver die off due to severe liver disease)
Hepatic steatosis (fatty liver disease)
Mass
Nipple exudate bloody (discharge from nipple with blood)

male:

Blood urea increased
Clostridium test positive
Dysphagia (a condition in which swallowing is difficult or painful)
Gasping (laboured breathing)
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
Hypoxia (low oxygen in tissues)
Interstitial lung disease
Low density lipoprotein increased (cholesterol increased in blood)
Lung disorder (lung disease)
Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Meprobamate and Haldol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Bradycardia (abnormally slow heart action)
Death
Dysphagia (a condition in which swallowing is difficult or painful)
Hypoxia (low oxygen in tissues)
Interstitial lung disease
Pyrexia (fever)
Respiratory distress (difficulty in breathing)

50-59:

Constipation
Diarrhoea
Dyspepsia (indigestion)
Nipple exudate bloody (discharge from nipple with blood)
Vaginal haemorrhage (vaginal bleeding)

60+:

Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic neoplasm (liver tumour)
Drug ineffective
Gasping (laboured breathing)
Hepatic necrosis (large portions of liver die off due to severe liver disease)
Hepatic steatosis (fatty liver disease)
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
Low density lipoprotein increased (cholesterol increased in blood)
Lung disorder (lung disease)
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Staphylococcal Bacteraemia (a bacterial infection of blood): 2 people, 18.18%
Proctitis Ulcerative (inflammation of the rectum and anus ulcerative): 2 people, 18.18%
High Blood Cholesterol: 1 person, 9.09%
Agitation (state of anxiety or nervous excitement): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Meprobamate and Haldol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously